Delivery Order SPE2DB20D2104-SPE2DB22FS80K

Award Date 5/20/22
Potential Completion Date 5/23/22
Potential Value $5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $10,356.87 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,935.52 firm fixed-price contract is for the supply of NASCOBAL 500 MCG nasal sprays. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,497.78 Firm Fixed Price Delivery Order is for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,699.92 Firm Fixed Price delivery order is for 4,560 units of NASCOBAL 500 MCG nasal sprays, with a completion date of March 22, 2023. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,559,338,389 units of NASCOBAL 500 MCG nasal sprays to the Defense Logistics Agency (DLA). The $6,068.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2022, with a completion date of December 12, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,338.26, is for the supply of NASCOBAL 500 MCG NASAL SPRAYS to support military healthcare programs. As an open competition contract with no set-aside designation, Amerisourcebergen was selected to provide these critical pharmaceutical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a ceiling value of $30,299.21 and is a Firm Fixed Price agreement. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $3,271.45 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 12, 2024 and was awarded on June 11, 2024. There is no set-aside designation noted for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of NASCOBAL 500 MCG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $1,733.87 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 12, 2022 and was awarded on April 11, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS80K
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Nascobal 500 mcg nasal sprays. The $5,039.89 firm fixed-price delivery order has a completion date of May 23, 2022. The contract does not have any set-aside designation, indicating open competition.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable the efficient government procurement of essential pharmaceuticals and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:52 AM